DK161736C - Grundmasse til skummende vaginalsuppositorium og vaginalsuppositorium fremstillet deraf - Google Patents

Grundmasse til skummende vaginalsuppositorium og vaginalsuppositorium fremstillet deraf

Info

Publication number
DK161736C
DK161736C DK105583A DK105583A DK161736C DK 161736 C DK161736 C DK 161736C DK 105583 A DK105583 A DK 105583A DK 105583 A DK105583 A DK 105583A DK 161736 C DK161736 C DK 161736C
Authority
DK
Denmark
Prior art keywords
vaginal
uppository
upposition
foaming
foundation
Prior art date
Application number
DK105583A
Other languages
English (en)
Other versions
DK105583A (da
DK161736B (da
DK105583D0 (da
Inventor
Toshio Kurobe
Masayoshi Kasai
Masanori Kayano
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK105583D0 publication Critical patent/DK105583D0/da
Publication of DK105583A publication Critical patent/DK105583A/da
Publication of DK161736B publication Critical patent/DK161736B/da
Application granted granted Critical
Publication of DK161736C publication Critical patent/DK161736C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
DK105583A 1982-03-05 1983-03-01 Grundmasse til skummende vaginalsuppositorium og vaginalsuppositorium fremstillet deraf DK161736C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57034034A JPS58152809A (ja) 1982-03-05 1982-03-05 安定な発泡性「膣」坐剤
JP3403482 1982-03-05

Publications (4)

Publication Number Publication Date
DK105583D0 DK105583D0 (da) 1983-03-01
DK105583A DK105583A (da) 1983-09-06
DK161736B DK161736B (da) 1991-08-12
DK161736C true DK161736C (da) 1992-01-27

Family

ID=12403050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK105583A DK161736C (da) 1982-03-05 1983-03-01 Grundmasse til skummende vaginalsuppositorium og vaginalsuppositorium fremstillet deraf

Country Status (7)

Country Link
US (1) US4853211A (da)
EP (1) EP0088394B1 (da)
JP (1) JPS58152809A (da)
KR (1) KR890000730B1 (da)
CA (1) CA1217719A (da)
DE (1) DE3364238D1 (da)
DK (1) DK161736C (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
US4999342A (en) * 1988-08-16 1991-03-12 Ortho Pharmaceutical Corporation Long lasting contraceptive suppository composition and methods of use
GR1000603B (el) * 1989-08-16 1992-08-26 Ortho Pharma Corp Μακρας διαρκειας αντισυλληπτικη συνθεσις υποθετου και μεθοδοι χρησεως.
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE4400375C2 (de) * 1994-01-08 1996-10-31 Schmittmann Hans Bernd Verwendung von erregerabtötend wirkenden Schäumen
FR2725371B1 (fr) * 1994-10-05 1997-08-29 Techni Pharma Nouveau procede de fabrication de suppositoires
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
MA24525A1 (fr) * 1997-04-14 1998-12-31 Procter & Gamble Particule detergente
EP0872544A1 (en) * 1997-04-14 1998-10-21 The Procter & Gamble Company Dry effervescent granules and granular compositions comprising the same
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6576250B1 (en) * 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20070178139A1 (en) * 1998-11-18 2007-08-02 Yankov Vladimir I Vaginally administratable progesterone-containing tablets and method for preparing same
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
US6426111B1 (en) 2000-06-02 2002-07-30 Gerald Phillip Hirsch Effervescent mixtures and methods of making
US20040047910A1 (en) * 2000-07-07 2004-03-11 Christian Beckett Suppository and composition comprising at least one polyethylene glycol
CA2345014C (en) * 2000-08-11 2010-04-20 Unilever Plc Packaged cosmetic effervescent cleansing pillow
WO2002024170A1 (en) * 2000-09-19 2002-03-28 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
JP4346311B2 (ja) * 2001-04-27 2009-10-21 京都薬品工業株式会社 発泡性坐剤の保存方法
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
CN102078310B (zh) * 2003-12-31 2013-01-23 奇马实验室公司 大体线性的泡腾口服芬太尼剂型和施用方法
BRPI0711525A2 (pt) * 2006-06-02 2011-11-01 Pear Tree Women S Health Care composição farmacêutica e método para tratar sintomas de vaginite atrófica
EP1872807A1 (en) * 2006-06-30 2008-01-02 Scil Technology GmbH Biomaterial containing degradation stabilized polymer
WO2008015138A2 (en) * 2006-08-03 2008-02-07 Ciba Holding Inc. Composition for improving wettability of surfaces
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA2700253A1 (en) * 2007-09-20 2009-03-21 Bio-Pro Medical Ltd. Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
UA105375C2 (uk) 2009-01-09 2014-05-12 Егіш Дьйодьсердьяр Нільваношан Мюкеде Ресвеньтаршашаг Спосіб виготовлення вагінального супозиторія
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
JPWO2015129800A1 (ja) * 2014-02-26 2017-03-30 セオリアファーマ株式会社 ジオクチルソジウムスルホサクシネート耳鼻科用液剤
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
US10966924B2 (en) * 2018-09-04 2021-04-06 Babak Ghalili Veterinary cannabinoid, menthol and anesthetic compositions and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1878766A (en) * 1928-11-26 1932-09-20 Gilbert F Fitzgerald Suppository for treating vaginal conditions
US3062715A (en) * 1953-11-18 1962-11-06 George S Pfaus Vaginal tablet
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
DE2213604C2 (de) * 1972-03-21 1975-08-14 Merz & Co, 6000 Frankfurt Vaginalzäpfchen zur Empfängnisverhütung
NL7302521A (en) * 1973-02-23 1974-08-27 Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
DE2602297B1 (de) * 1976-01-22 1977-01-13 Merz & Co Vaginalzaepfchen zur empfaengnisverhuetung mit einem gehalt an milchalbumin
FR2358891A1 (fr) * 1976-07-22 1978-02-17 Yamanouchi Pharma Co Ltd Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires
US4187286A (en) * 1979-01-02 1980-02-05 G&W Laboratories, Inc. Contraceptive suppository
US4322399A (en) * 1979-10-19 1982-03-30 Ortho Pharmaceutical Corporation Vaginal suppository

Also Published As

Publication number Publication date
CA1217719A (en) 1987-02-10
DK105583A (da) 1983-09-06
KR840003811A (ko) 1984-10-04
EP0088394A3 (en) 1983-10-12
JPS58152809A (ja) 1983-09-10
EP0088394A2 (en) 1983-09-14
DE3364238D1 (en) 1986-07-31
KR890000730B1 (ko) 1989-04-03
DK161736B (da) 1991-08-12
DK105583D0 (da) 1983-03-01
EP0088394B1 (en) 1986-06-25
US4853211A (en) 1989-08-01

Similar Documents

Publication Publication Date Title
DK161736C (da) Grundmasse til skummende vaginalsuppositorium og vaginalsuppositorium fremstillet deraf
DK190583D0 (da) System og metode til celleudvaelgelse
DK100484D0 (da) Gangtoej og fremgangsmade til at fremstille gangtoej
DK493583A (da) Azolderivater og fremgangsmaade til fremstilling deraf
DK161215C (da) Belastningscelle og fremgangsmaade til fremstilling heraf
DK304781A (da) Formdel og fremgansmaade til fremstolling heraf
DK493882A (da) Faeldningskiselsyre og fremgangsmaade til fremstilling deraf
DK276683D0 (da) Carbapenemer og fremgangsmade til fremstilling deraf
DK443683D0 (da) Triazolforbindelser og fremgangsmader til deres fremstilling
DK253083D0 (da) Amidiner og fremgangsmade til fremstilling deraf
DK157683A (da) N-phosphonomethylglycinderivater og fremgangsmaade til fremstilling og anvendelse deraf
DK102182A (da) Vandfrit antitranspirationsmiddel og fremgangsmaade til fremstilling deraf
DK567781A (da) Phenoxyalkoxysilaner og fremgangsmaade til fremstilling heraf
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK537481A (da) 5-amino-1-phenyl-4-cyanpyrazoler og fremgangsmaade til fremstilling heraf
DK621484D0 (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK271281A (da) Haardfeldt og fremgangsmaade til fremstilling deraf
DK297583A (da) Tricycliske forbindelser og fremgangsmaade til fremstilling heraf
DK242881A (da) Forstaerket plade og fremgangsmaade til fremstilling deraf
DK343183D0 (da) Ketoquinoliner og fremgangsmade til fremstilling deraf
DK129983A (da) 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser og fremgangsmaader til fremstilling deraf
DK81192A (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK196683D0 (da) Substitueret urinstof og herbicid indeholdende dette
DK90083D0 (da) Isoxazolopyrimidinderivater og fremgangsmade til fremstilling deraf

Legal Events

Date Code Title Description
PBP Patent lapsed